SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950168-03-000376
Filing Date
2003-02-07
Accepted
2003-02-07 14:36:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 FREDRIC N. ESHELMAN dsc13ga.htm SC 13G/A 38377
  Complete submission text file 0000950168-03-000376.txt   40313
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48083 | Film No.: 03544376
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412
Business Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412 9102510081
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)